MedTrace Logo

Semitendinosus Graft as Meniscal Transplant

NCT04753424 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-06-23

No results posted yet for this study

Summary

Removal of meniscal tissue is described to result in poor knee function and a significant risk for future development of osteoarthritis. Different implants have been suggested to substitute a removed meniscus. Meniscal allograft transplantation is not widely available due to costs and availability. The semitendinosus tendon is a known graft with biological properties with potential to remodel and revascularize in an intraarticular environment such as anterior cruciate ligament reconstruction. The objective for this study was to investigate whether the semitendinosus tendon graft could function as a meniscal transplant.

Conditions

  • Patient Satisfaction
  • Graft Failure
  • Osteo Arthritis Knee
  • ACL
  • Meniscus Tear

Interventions

PROCEDURE

Surgical technique

Description of novel surgical technique using autologous semitendinosus graft as meniscus transplant.

Sponsors & Collaborators

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2024-01-01
Completion
2026-01-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04753424 on ClinicalTrials.gov